← FDA WARNING LETTERS
FDA WARNING LETTER27 February 2018

Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy — FDA Warning Letter

Company
Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy
Letter date
27 February 2018
CHECKING ACCESS

Checking your Professional access…

DON’T BE THE NEXT LETTER
Assess your quality systemBaseline against 12 GxP domains in 10 minutes →Decode the standardsThe requirements behind the citations →All warning lettersBrowse the live FDA feed →

Warning-letter details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.